First Circuit Rejects Whistleblower’s Fraud on the FDA FCA Theory

In a recent decision, the First Circuit rejected a relator’s claim that a medical device manufacturer caused the submission of false claims for Medicare reimbursement by fraudulently obtaining Food and Drug Administration approval of one of its devices.